Source:http://linkedlifedata.com/resource/pubmed/id/18989994
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
6
|
| pubmed:dateCreated |
2008-11-7
|
| pubmed:abstractText |
BACKGROU nd and objective: Behçet's disease (BD) is a polysymptomatic condition characterized by recurrent oral and genital ulceration and uveitis. Aphthous stomatitis, a common complication, is painful, recurrent and sometimes resistant to treatment. Topical or intralesional corticosteroids and local anaesthetics are used for palliative therapy. We investigated whether irsogladine, a drug for the treatment of gastritis and peptic ulcers, reduced aphthous stomatitis lesions in patients with BD.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
1174-5886
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
9
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
455-9
|
| pubmed:meshHeading |
pubmed-meshheading:18989994-Administration, Oral,
pubmed-meshheading:18989994-Adult,
pubmed-meshheading:18989994-Anti-Ulcer Agents,
pubmed-meshheading:18989994-Behcet Syndrome,
pubmed-meshheading:18989994-Cell Communication,
pubmed-meshheading:18989994-Female,
pubmed-meshheading:18989994-Follow-Up Studies,
pubmed-meshheading:18989994-Gap Junctions,
pubmed-meshheading:18989994-Humans,
pubmed-meshheading:18989994-Male,
pubmed-meshheading:18989994-Middle Aged,
pubmed-meshheading:18989994-Recurrence,
pubmed-meshheading:18989994-Stomatitis, Aphthous,
pubmed-meshheading:18989994-Triazines
|
| pubmed:year |
2008
|
| pubmed:articleTitle |
Irsogladine is effective for recurrent oral ulcers in patients with Behçet's disease : an open-label, single-centre study.
|
| pubmed:affiliation |
Institute of Rheumatology, Tokyo Women's Medical University, Shinjuku-ku, Tokyo, Japan.
|
| pubmed:publicationType |
Journal Article,
Clinical Trial
|